Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12–49

PubMed  Google Scholar 

Park CH, Song CM, Ji YB et al (2015) Significance of the extracapsular spread of metastatic lymph nodes in papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 8:289–294

PubMed  PubMed Central  Google Scholar 

Miranda-Filho A, Lortet-Tieulent J, Bray F et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225–234

PubMed  Google Scholar 

Lai SW, Fan YL, Zhu YH et al (2022) Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front Endocrinol (Lausanne) 13:1019037

PubMed  Google Scholar 

Xing Z, Qiu Y, Yang Q et al (2020) Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol 129:109103

PubMed  Google Scholar 

Renkonen S, Linden R, Back L et al (2017) Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 274:3977–3983

PubMed  PubMed Central  Google Scholar 

Piscopo L, Nappi C, Volpe F et al (2022) Prognostic value of hybrid PET/MR imaging in patients with differentiated thyroid cancer. Cancers (Basel) 14:2958

PubMed  CAS  Google Scholar 

Song Y, Liu F, Ruan W et al (2021) Head-to-head comparison of neck (18)F-FDG PET/MR and PET/CT in the diagnosis of differentiated thyroid carcinoma patients after comprehensive treatment. Cancers (Basel) 13:3436

PubMed  CAS  Google Scholar 

Klain M, Nappi C, Nicolai E et al (2020) Comparison of simultaneous (18)F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 47:3066–3073

PubMed  CAS  Google Scholar 

Vrachimis A, Burg MC, Wenning C et al (2016) [(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 43:212–220

PubMed  CAS  Google Scholar 

Wang Y, Liu Y, Geng H, Zhang W (2023) Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment. EJNMMI Res 13:109

PubMed  PubMed Central  Google Scholar 

Rizzo A, Albano D, Dondi F et al (2024) Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review. Front Med (Lausanne) 11:1381863

PubMed  Google Scholar 

Fu H, Wu J, Huang J et al (2022) (68)Ga fibroblast activation protein inhibitor PET/CT in the detection of metastatic thyroid cancer: comparison with (18)F-FDG PET/CT. Radiology 304:397–405

PubMed  Google Scholar 

Mu X, Huang X, Jiang Z et al (2023) [(18)F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 50:1205–1215

PubMed  CAS  Google Scholar 

Chen Y, Zheng S, Zhang J, Yao S, Miao W (2022) (68)Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients. Ann Nucl Med 36:610–622

PubMed  CAS  Google Scholar 

Parascandolo A, Rappa F, Cappello F et al (2017) Extracellular superoxide dismutase expression in papillary thyroid cancer mesenchymal stem/stromal cells modulates cancer cell growth and migration. Sci Rep 7:41416

PubMed  PubMed Central  CAS  Google Scholar 

Renkonen S, Lindén R, Bäck L et al (2017) Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 274:3977–3983

PubMed  PubMed Central  Google Scholar 

Seo YL, Yoon DY, Baek S et al (2012) Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer). Eur Radiol 22:2246–2254

PubMed  Google Scholar 

Leboulleux S, Girard E, Rose M et al (2007) Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590–3594

PubMed  CAS  Google Scholar 

Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537 quiz 1538–1540

Grant AM, Deller TW, Khalighi MM, Maramraju SH, Delso G, Levin CS (2016) NEMA NU 2–2012 performance studies for the SiPM-based ToF-PET component of the GE SIGNA PET/MR system. Med Phys 43:2334

PubMed  Google Scholar 

Binse I, Poeppel TD, Ruhlmann M et al (2016) Imaging with (124)I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? Eur J Nucl Med Mol Imaging 43:1011–1017

PubMed  CAS  Google Scholar 

Suh CH, Baek JH, Choi YJ, Lee JH (2017) Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol 38:154–161

PubMed  PubMed Central  CAS  Google Scholar 

Wu LM, Gu HY, Qu XH et al (2012) The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis. Eur J Radiol 81:1798–1805

PubMed  Google Scholar 

Lasek W (2022) Cancer immunoediting hypothesis: history, clinical implications and controversies. Cent Eur J Immunol 47:168–174

PubMed  PubMed Central  CAS  Google Scholar 

Gilardi L, Airò Farulla LS, Demirci E, Clerici I, Omodeo Salè E, Ceci F (2022) Imaging cancer-associated fibroblasts (CAFs) with FAPi PET. Biomedicines 10:523

PubMed  PubMed Central  CAS  Google Scholar 

Lindner T, Giesel FL, Kratochwil C, Serfling SE (2021) Radioligands targeting fibroblast activation protein (FAP). Cancers (Basel) 13:5744

PubMed  CAS  Google Scholar 

Hathi DK, Jones EF (2019) (68)Ga FAPI PET/CT: tracer uptake in 28 different kinds of cancer. Radiol Imaging Cancer 1:e194003

PubMed  PubMed Central  Google Scholar 

Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U (2023) FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology 306:e220749

PubMed  Google Scholar 

Chen Y, Zheng S, Zang J et al (2024) [(68)Ga]Ga-LNC1007 versus 2-[(18)F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study. Eur J Nucl Med Mol Imaging 52:683–692

PubMed  Google Scholar 

Sun WY, Jung WH, Koo JS (2016) Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Tumour Biol 37:8197–8207

PubMed  CAS  Google Scholar 

Ham J, Wang B, Po JW, Singh A, Niles N, Lee CS (2021) Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions. J Clin Pathol 74:759–765

PubMed  CAS  Google Scholar 

Jolly LA, Novitskiy S, Owens P et al (2016) Fibroblast-mediated collagen remodeling within the tumor microenvironment facilitates progression of thyroid cancers driven by BrafV600E and Pten loss. Cancer Res 76:1804–1813

PubMed  PubMed Central  CAS  Google Scholar 

Shangguan C, Gan G, Zhang J et al (2018) Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT. Theranostics 8:1376–1388

PubMed  PubMed Central  CAS  Google Scholar 

Dohán O, Carrasco N (2003) Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 213:59–70

PubMed  Google Scholar 

Duarte PS, Marin JFG, de Carvalho JWA, Sapienza MT, Buchpiguel CA (2018) Iodine/FDG “Flip-Flop” phenomenon inside a large metastatic thyroid cancer lesion better characterized on SPECT/CT and PET/CT Studies. Clin Nucl Med 43:436–438

PubMed  Google Scholar 

Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M (2020) Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal 18:83

PubMed  PubMed Central  CAS  Google Scholar 

Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS, Jeon YK (2013) The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr Relat Cancer 20:R203-213

PubMed  CAS  Google Scholar 

Luster M, Aktolun C, Amendoeira I, et al. (2019) European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: Proceedings of an interactive international symposium. Thyroid 29:7–26

Chen H, Zhao L, Pang Y et al (2024) 68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer. J Clin Invest 135:e185408

PubMed  PubMed Central  Google Scholar